Meeder Asset Management’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-119
| Closed | -$1K | – | 2706 |
|
|
2021
Q1 | $1K | Buy |
+119
| New | +$1K | ﹤0.01% | 2282 |
|
|
2020
Q4 | – | Sell |
-119
| Closed | -$2K | – | 2288 |
|
|
2020
Q3 | $2K | Sell |
119
-121
| -50% | -$2.03K | ﹤0.01% | 1887 |
|
|
2020
Q2 | $4K | Hold |
240
| – | – | ﹤0.01% | 1621 |
|
|
2020
Q1 | $2K | Sell |
240
-179
| -43% | -$1.49K | ﹤0.01% | 2127 |
|
|
2019
Q4 | $10K | Sell |
419
-352
| -46% | -$8.4K | ﹤0.01% | 1575 |
|
|
2019
Q3 | $11K | Buy |
771
+507
| +192% | +$7.23K | ﹤0.01% | 1514 |
|
|
2019
Q2 | $4K | Hold |
264
| – | – | ﹤0.01% | 1753 |
|
|
2019
Q1 | $5K | Hold |
264
| – | – | ﹤0.01% | 1414 |
|
|
2018
Q4 | $4K | Sell |
264
-12
| -4% | -$182 | ﹤0.01% | 1477 |
|
|
2018
Q3 | $6K | Buy |
+276
| New | +$6K | ﹤0.01% | 1302 |
|
|
2018
Q2 | – | Sell |
-20
| Closed | -$1K | – | 1709 |
|
|
2018
Q1 | $1K | Buy |
20
+6
| +43% | +$300 | ﹤0.01% | 1492 |
|
|
2017
Q4 | $1K | Sell |
14
-1
| -7% | -$71 | ﹤0.01% | 1605 |
|
|
2017
Q3 | $1K | Sell |
15
-11
| -42% | -$733 | ﹤0.01% | 1576 |
|
|
2017
Q2 | $2K | Sell |
26
-4
| -13% | -$308 | ﹤0.01% | 1439 |
|
|
2017
Q1 | $7K | Sell |
30
-302
| -91% | -$70.5K | ﹤0.01% | 970 |
|
|
2016
Q4 | $30K | Buy |
+332
| New | +$30K | ﹤0.01% | 611 |
|